520 related articles for article (PubMed ID: 30045991)
41. Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin.
Wang W; Alvarado-Facundo E; Vassell R; Collins L; Colombo RE; Ganesan A; Geaney C; Hrncir D; Lalani T; Markelz AE; Maves RC; McClenathan B; Mende K; Richard SA; Schofield C; Seshadri S; Spooner C; Utz GC; Warkentien TE; Levine M; Coles CL; Burgess TH; Eichelberger M; Weiss CD
Clin Infect Dis; 2021 Dec; 73(11):e4312-e4320. PubMed ID: 32898271
[TBL] [Abstract][Full Text] [Related]
42. Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance.
Liu STH; Behzadi MA; Sun W; Freyn AW; Liu WC; Broecker F; Albrecht RA; Bouvier NM; Simon V; Nachbagauer R; Krammer F; Palese P
J Clin Invest; 2018 Nov; 128(11):4992-4996. PubMed ID: 30188868
[TBL] [Abstract][Full Text] [Related]
43. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
44. Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza Vaccine Candidates by Human Antibodies.
Abbadi N; Nagashima K; Pena-Briseno A; Ross TM; Mousa JJ
J Virol; 2022 Aug; 96(16):e0089622. PubMed ID: 35916534
[TBL] [Abstract][Full Text] [Related]
45. Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans.
Zhong W; Gross FL; Holiday C; Jefferson SN; Bai Y; Liu F; Katz JM; Levine MZ
Viral Immunol; 2016 May; 29(4):259-62. PubMed ID: 26950058
[TBL] [Abstract][Full Text] [Related]
46. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
[TBL] [Abstract][Full Text] [Related]
47. Development and characterization of a panel of cross-reactive monoclonal antibodies generated using H1N1 influenza virus.
Guo CY; Tang YG; Qi ZL; Liu Y; Zhao XR; Huo XP; Li Y; Feng Q; Zhao PH; Wang X; Li Y; Wang HF; Hu J; Zhang XJ
Immunobiology; 2015 Aug; 220(8):941-6. PubMed ID: 25708705
[TBL] [Abstract][Full Text] [Related]
48. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.
Wang S; Taaffe J; Parker C; Solórzano A; Cao H; García-Sastre A; Lu S
J Virol; 2006 Dec; 80(23):11628-37. PubMed ID: 16987975
[TBL] [Abstract][Full Text] [Related]
49. Changed epitopes drive the antigenic drift for influenza A (H3N2) viruses.
Huang JW; Yang JM
BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S31. PubMed ID: 21342562
[TBL] [Abstract][Full Text] [Related]
50. Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011-2018.
Jorquera PA; Mishin VP; Chesnokov A; Nguyen HT; Mann B; Garten R; Barnes J; Hodges E; De La Cruz J; Xu X; Katz J; Wentworth DE; Gubareva LV
Sci Rep; 2019 Feb; 9(1):2676. PubMed ID: 30804469
[TBL] [Abstract][Full Text] [Related]
51. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
[TBL] [Abstract][Full Text] [Related]
52. Influence of adjuvants on the amount, specificity and functional activity of antibody response to human influenza vaccine in mice.
Voutssas-Lara J; Cervantes-Torres J; Hernández M; Bobes RJ; Lamoyi E; Vázquez-Ramírez RA; Mendoza L; Reyes-Barrera KL; López-Martínez R; Alpuche-Solís ÁG; Rosales-Mendoza S; Huerta L; Fragoso G; Sciutto E
Mol Immunol; 2021 Jul; 135():398-407. PubMed ID: 34022515
[TBL] [Abstract][Full Text] [Related]
53. An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice.
Abdoli A; Soleimanjahi H; Tavassoti Kheiri M; Jamali A; Mazaheri V; Abdollahpour Alitappeh M
Pathog Dis; 2014 Dec; 72(3):197-207. PubMed ID: 25066138
[TBL] [Abstract][Full Text] [Related]
54. VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
Kuck LR; Byrne-Nash R; Gillis J; Bueter K; Couzens LK; Eichelberger MC; Rowlen KL
Vaccine; 2018 May; 36(21):2937-2945. PubMed ID: 29699789
[TBL] [Abstract][Full Text] [Related]
55. Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.
Ermler ME; Kirkpatrick E; Sun W; Hai R; Amanat F; Chromikova V; Palese P; Krammer F
J Virol; 2017 Jun; 91(12):. PubMed ID: 28356526
[TBL] [Abstract][Full Text] [Related]
56. Migration of the swine influenza virus δ-cluster hemagglutinin N-linked glycosylation site from N142 to N144 results in loss of antibody cross-reactivity.
Hause BM; Stine DL; Sheng Z; Wang Z; Chakravarty S; Simonson RR; Li F
Clin Vaccine Immunol; 2012 Sep; 19(9):1457-64. PubMed ID: 22815146
[TBL] [Abstract][Full Text] [Related]
57. Development of broadly reactive H5N1 vaccine against different Egyptian H5N1 viruses.
Ibrahim M; Sultan HA; Razik AG; Kang KI; Arafa AS; Shehata AA; Saif YM; Lee CW
Vaccine; 2015 May; 33(23):2670-7. PubMed ID: 25910922
[TBL] [Abstract][Full Text] [Related]
58. Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies.
Nakajima R; Supnet M; Jasinskas A; Jain A; Taghavian O; Obiero J; Milton DK; Chen WH; Grantham M; Webby R; Krammer F; Carter D; Felgner PL; Davies DH
mSphere; 2018 Dec; 3(6):. PubMed ID: 30541779
[TBL] [Abstract][Full Text] [Related]
59. Antigenic sites of H1N1 influenza virus hemagglutinin revealed by natural isolates and inhibition assays.
Huang JW; Lin WF; Yang JM
Vaccine; 2012 Sep; 30(44):6327-37. PubMed ID: 22885274
[TBL] [Abstract][Full Text] [Related]
60. Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs.
Xu J; Huang D; Liu S; Lin H; Zhu H; Liu B; Lu C
Virus Res; 2012 Aug; 167(2):188-95. PubMed ID: 22584406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
